Researchers from University of California, San Diego (UCSD) identified a steriod-based organic compound, named lanosterol. Lanosterol has the ability to dissolve the protein formations that cause cataracts and eliminate blurry vision, both in elderly people and children who develop this condition due to genetic mutations.
The study showed the effect of lanosterol in cataract formation in dogs who had the disease. It was observed that the substance improved the eye-sight of the dogs within six weeks, by clearing their vision completely.
Dr. Kang Zhang from the UCSD’s Shiley Eye Institute states that, if the clinical trial on human patients is successful, people suffering with cataracts will for the fist time benefit a non-invasive eye-drops treatment solution. Currently, cataracts can only be cured by undergoing surgery of cloudy crystalline eye-lens replacement.
Californian team adds that lanosterol treatment may be long-term and, in some cases, permanent.